Old Web
English
Sign In
Acemap
>
authorDetail
>
Donna S. Cox
Donna S. Cox
Pfizer
Medicine
Pharmacokinetics
Active metabolite
Pharmacology
Cmax
3
Papers
8
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Randomized, Open-Label, Single-Dose, Parallel-Group Pharmacokinetic Study of PF-06410293 (adalimumab-afzb), an Adalimumab Biosimilar, by Subcutaneous Dosing Using a Prefilled Syringe or a Prefilled Pen in Healthy Subjects.
2021
Clinical pharmacology in drug development
Donna S. Cox
Daniel F. Alvarez
Amy E. Bock
Carol Cronenberger
Show All
Source
Cite
Save
Citations (0)
Pharmacokinetic and Metabolic Profile of Deutetrabenazine (TEV-50717) Compared With Tetrabenazine in Healthy Volunteers.
2020
Clinical and Translational Science
Frank Schneider
Margaret Bradbury
Thomas A. Baillie
David Stamler
Edward Hellriegel
Donna S. Cox
Pippa S. Loupe
Juha-Matti Savola
Laura Rabinovich-Guilatt
Show All
Source
Cite
Save
Citations (6)
Pharmacokinetics of Deutetrabenazine and Tetrabenazine: Dose Proportionality and Food Effect.
2020
Clinical pharmacology in drug development
Frank Schneider
David Stamler
Margaret Bradbury
Pippa S. Loupe
Edward T. Hellriegel
Donna S. Cox
Juha-Matti Savola
Mark Forrest Gordon
Laura Rabinovich-Guilatt
Show All
Source
Cite
Save
Citations (2)
1